Skip to main content

Table 3 Comparison of clinical data between the groups of Kawasaki disease (KD) with and without Grisel syndrome (GS)

From: Grisel’s syndrome in Kawasaki disease

 

KD with GS

(n = 10)

KD without GS

(n = 1254)

p value

Male, n (%)

2(20.0)

731(58.3)

0.021

Age, years

5.9(4.3–6.7)

2.2(1.2–3.6)

<0.001

Clinical manifestations

 Rash

5(50.0)

939(74.9)

0.134

 Edema & erythema of the extremities

3(30.0)

715(57.0)

0.111

 Bilateral bulbar conjunctive injection

8(80.0)

1138(90.7)

0.226

 Erythema of oral and pharyngeal mucosa

8(80.0)

1142 (91.1)

0.256

 Cervical lymphadenopathy

10(100.0)

647(51.6)

0.002

 Fever duration before IVIG administration, days

6.0(4.8–7.3)

6.0(5.0–7.0)

0.916

 Incomplete KD

6(60.0)

460(36.7)

0.186

 IVIG resistance

0(0.00)

188(15.0)

0.374

 Coronary artery lesions

0(0.00)

125(10.6)

0.292

Laboratory examinations

 White blood cell, ×109/L

14.6(12.5–18.8)

14.0(11.0–17.4)

0.744

 Neutrophil count, %

79.9(77.2–91.7)

68.3(58.0–78.6)

0.001

 Hemoglobin, g/L

108.0(99.3–117.5)

109.0(102.0–116.0)

0.737

 Platelet count, ×109/L

313(268–350)

325(267–395)

0.344

 C-reactive protein, mg/L

111.0(69.5–155.5)

76.0(45.0–114.0)

0.155

 Erythrocyte sedimentation rate, mm/h

102.0(59.0–124.0)

66.0(46.0–87.0)

0.018

 Aspartate aminotransferase, U/L

34.5(27.0–56.5)

34.0(26.0–52.0)

0.573

 Alanine aminotransferase, U/L

25.5(13.0–39.0)

37.0(21.0–79.0)

0.332

 Albumin, g/L

36.0(31.7–42.3)

37.5(34.1–40.9)

0.667

 Total bilirubin, umol/L

9.2(7.1–15.5)

6.3(4.0–10.0)

0.858

 Creatinine, umol/L

30.0(25.0–41.5)

28.0(23.0–33.0)

0.839

 Urea nitrogen, umol/L

2.7(2.3–4.9)

2.9(2.2–4.0)

0.429

 Serum sodium, mmol/L

138.2(135.1–138.2)

136.9(134.0–139.0)

0.880

 Potassium, mmol/L

4.0(3.7–4.1)

4.1(3.7–4.5)

0.396

  1. The data are presented as the median with the 25th and 75th percentiles in square brackets for continuous variables and as n/% for qualitative data as appropriate